These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11882550)

  • 1. Newborn screening for Duchenne muscular dystrophy: a psychosocial study.
    Parsons EP; Clarke AJ; Hood K; Lycett E; Bradley DM
    Arch Dis Child Fetal Neonatal Ed; 2002 Mar; 86(2):F91-5. PubMed ID: 11882550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of carrier identification in newborn screening for cystic fibrosis.
    Parsons EP; Clarke AJ; Bradley DM
    Arch Dis Child Fetal Neonatal Ed; 2003 Nov; 88(6):F467-71. PubMed ID: 14602692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parental attitudes toward newborn screening for Duchenne/Becker muscular dystrophy and spinal muscular atrophy.
    Wood MF; Hughes SC; Hache LP; Naylor EW; Abdel-Hamid HZ; Barmada MM; Dobrowolski SF; Stickler DE; Clemens PR
    Muscle Nerve; 2014 Jun; 49(6):822-8. PubMed ID: 24307279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK).
    Moat SJ; Bradley DM; Salmon R; Clarke A; Hartley L
    Eur J Hum Genet; 2013 Oct; 21(10):1049-53. PubMed ID: 23340516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children.
    Hiraki S; Ormond KE; Kim K; Ross LF
    Am J Med Genet A; 2006 Nov; 140(21):2312-9. PubMed ID: 17036312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy.
    Ross LF
    Am J Med Genet A; 2006 Apr; 140(8):914-22. PubMed ID: 16528755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental progress in Duchenne muscular dystrophy: lessons for earlier detection.
    Parsons EP; Clarke AJ; Bradley DM
    Eur J Paediatr Neurol; 2004; 8(3):145-53. PubMed ID: 15120686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatricians' attitudes toward expanding newborn screening.
    Acharya K; Ackerman PD; Ross LF
    Pediatrics; 2005 Oct; 116(4):e476-84. PubMed ID: 16199673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with screening newborns for Duchenne muscular dystrophy in Wales.
    Bradley DM; Parsons EP; Clarke AJ
    BMJ; 1993 Feb; 306(6874):357-60. PubMed ID: 8461680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal screening for treatable and untreatable disorders: prospective parents' opinions.
    Plass AM; van El CG; Pieters T; Cornel MC
    Pediatrics; 2010 Jan; 125(1):e99-106. PubMed ID: 20026497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Follow-Up for Duchenne Muscular Dystrophy Newborn Screening: A Proposal.
    Kwon JM; Abdel-Hamid HZ; Al-Zaidy SA; Mendell JR; Kennedy A; Kinnett K; Cwik VA; Street N; Bolen J; Day JW; Connolly AM
    Muscle Nerve; 2016 Aug; 54(2):186-91. PubMed ID: 27170260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-year follow-up of newborn screening for patients with muscular dystrophy.
    Chung J; Smith AL; Hughes SC; Niizawa G; Abdel-Hamid HZ; Naylor EW; Hughes T; Clemens PR
    Muscle Nerve; 2016 Apr; 53(4):570-8. PubMed ID: 26260293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress.
    Waisbren SE; Albers S; Amato S; Ampola M; Brewster TG; Demmer L; Eaton RB; Greenstein R; Korson M; Larson C; Marsden D; Msall M; Naylor EW; Pueschel S; Seashore M; Shih VE; Levy HL
    JAMA; 2003 Nov; 290(19):2564-72. PubMed ID: 14625333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parental attitudes regarding newborn screening of PKU and DMD.
    Campbell E; Ross LF
    Am J Med Genet A; 2003 Jul; 120A(2):209-14. PubMed ID: 12833401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Duchenne muscular dystrophy in Germany, 1977-2011: A personal story.
    Scheuerbrandt G
    Muscle Nerve; 2018 Feb; 57(2):185-188. PubMed ID: 28981144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal psychological reaction to newborn genetic screening for type 1 diabetes.
    Kerruish NJ; Campbell-Stokes PL; Gray A; Merriman TR; Robertson SP; Taylor BJ
    Pediatrics; 2007 Aug; 120(2):e324-35. PubMed ID: 17609310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic experiences of Duchenne families and their preferences for newborn screening: A mixed-methods study.
    Crossnohere NL; Armstrong N; Fischer R; Bridges JFP
    Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):169-177. PubMed ID: 35943031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
    Tluczek A; Koscik RL; Farrell PM; Rock MJ
    Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.